Here are four key points:
1. With this partnership, Implanet markets in 17 countries.
2. Implanet will now have access to Australia’s $120 million vertebral fusion market, to offer its Jazz products.
3. Implanet also integrated its Jazz Claw into the Australian Register of Therapeutic Goods.
4. Jazz is designed to treat spinal pathologies with vertebral fusion surgery.
More articles on devices:
Medtronic unveils sacral fracture-treating bone cement — 5 observations
DJO Global unveils Altivate Anatomic Shoulder System: 4 things to know
Why AdvaMed supports AHCA: 6 key reasons
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
